cardiomyocytes

1.
Saif F. Dababneh, Hosna Babini, Verónica Jiménez-Sábado, Sheila S. Teves, Kyoung-Han Kim, Glen F. Tibbits. Dissecting cardiovascular disease-associated noncoding genetic variants using human iPSC models. Stem Cell Reports. 2025;20(4). doi:10.1016/j.stemcr.2025.102467
View Full Reference
1.
Tromondae K. Feaster, Jourdan K. Ewoldt, Anna Avila, et al. Nonclinical evaluation of chronic cardiac contractility modulation on 3D human engineered cardiac tissues. Journal of Cardiovascular Electrophysiology. 2024;35(5):895-905. doi:10.1111/jce.16222
View Full Reference
1.
Bérénice Charrez, Verena Charwat, Brian A. Siemons, et al. Heart Muscle Microphysiological System for Cardiac Liability Prediction of Repurposed COVID-19 Therapeutics. Frontiers in Pharmacology. 2021;12:684252. doi:10.3389/fphar.2021.684252
View Full Reference
1.
Arun Sharma, Gustavo Garcia, Yizhou Wang, et al. Human iPSC-Derived Cardiomyocytes Are Susceptible to SARS-CoV-2 Infection. Cell Reports. Medicine. 2020;1(4):100052. doi:10.1016/j.xcrm.2020.100052
View Full Reference